7-I-7-deaza-2'-deoxyadenosine is a modified nucleoside analog. Its structure features a 7-deaza-7-iodo modification on the purine base and a 2'-deoxyribose sugar moiety. This specific halogenation at the 7-position of the deazaadenine ring is a key structural alteration. This compound serves as a crucial intermediate in the synthesis of nucleoside-based antiviral and anticancer agents. It is particularly important in the development of chain-terminating inhibitors for viral polymerases. For instance, it is a key precursor in the synthesis of certain 2'-deoxy-7-deazapurine nucleoside analogs investigated for their biological activity. As a specialized building block, it is used in medicinal chemistry research to explore structure-activity relationships and to create novel therapeutic candidates targeting DNA/RNA synthesis pathways. Its handling requires standard precautions for potentially bioactive organic compounds.